Access to a non-invasive test shouldn't depend on where someone lives or which local service has managed to adopt it first, ...

Five hospitals in England and Wales have switched to urine test, rather than invasive hospital procedure ...

Marks third NCCN guideline recommendation on ctDNA-MRD testing, following positive guideline changes in merkel cell carcinoma and diffuse large b-cell lymphoma Natera, Inc. (NASDAQ: NTRA), a global ...

Bladder cancer arises from the lining of the bladder, the organ that stores urine, and is one of the most common cancers in the United States. Most patients are diagnosed at an early stage called ...

Circulating tumor DNA, or ctDNA, can predict metastatic risk in patients who receive bladder-sparing treatment for muscle-invasive bladder cancer, but it is not a good predictor of local recurrence ...

It provides patients with a less painful and invasive screening option. Read more at straitstimes.com. Read more at ...

Researchers at MD Anderson Cancer Center have used spatial transcriptomics to chart the internal architecture of ...

Bladder cancer does not always announce itself with dramatic pain or a sudden health crisis. In many people, the earliest bladder cancer symptoms look ordinary, brief, or easy to dismiss. A little ...

Source: Getty Images A growing body of research seeks to validate ctDNA as a means of guiding MIBC treatment, particularly immunotherapy. [Editor’s note: This article was updated in June 2026 from its ...

Researchers at The University of Texas MD Anderson Cancer Center have developed a spatial map of muscle-invasive bladder cancer, revealing how tumor cell states, immune environments and therapeutic ...